80
True
United States
The website reports a rise in extensively drug-resistant shigella infections in the U.S., with cases increasing from 0% in 2011-2015 to 8.5% in 2023. The CDC identified 510 cases in 2023, and no FDA-approved oral treatments are available.
The claims regarding the rise of extensively drug-resistant Shigella infections in the U.S. are well-supported by multiple sources, including the CDC. The statistical data about the increase in cases from 0% to 8.5% and the identification of 510 cases in 2023 are corroborated by several authoritative sources. Additionally, the lack of FDA-approved oral treatments for these infections is confirmed by the CDC and other health advisories. Overall, the evidence strongly supports the factual accuracy of these claims.
Individual Claims
85
True
Health
Cases of extensively drug-resistant shigella infections are rising in the U.S.
Multiple sources, including the CDC, confirm that cases of extensively drug-resistant Shigella infections are increasing in the U.S. This is supported by evidence from the CDC and other health advisories.
Fact Check Score
None
Fact Check Weight
0
Web Consensus Score
95
Web Consensus Weight
50
Source Quality Score
90
Source Quality Weight
25
Llm Reasoning Score
85
Llm Reasoning Weight
25
Weighted Total
85
Evidence Summary
Multiple web sources confirm the rise of drug-resistant Shigella in the U.S.
80
True
Health
Cases of drug-resistant shigella went from 0% in 2011 through 2015 to 8.5% in 2023.
The CDC and multiple news sources report that the percentage of drug-resistant Shigella cases increased from 0% during 2011-2015 to 8.5% in 2023, confirming the claim.
Fact Check Score
None
Fact Check Weight
0
Web Consensus Score
90
Web Consensus Weight
50
Source Quality Score
85
Source Quality Weight
25
Llm Reasoning Score
80
Llm Reasoning Weight
25
Weighted Total
80
Evidence Summary
CDC and multiple sources confirm the increase from 0% to 8.5%.
76
Mostly True
Health
The first isolates of drug-resistant shigella strains were identified in 2016.
Evidence from the CDC and other sources indicates that the first drug-resistant Shigella strains were identified in 2016, supporting the claim.
Fact Check Score
None
Fact Check Weight
0
Web Consensus Score
85
Web Consensus Weight
50
Source Quality Score
80
Source Quality Weight
25
Llm Reasoning Score
75
Llm Reasoning Weight
25
Weighted Total
76
Evidence Summary
CDC and other sources confirm the identification of strains in 2016.
78
Mostly True
Health
By 2023, 510 drug-resistant shigella cases were identified within 10 months.
The CDC and other sources report that 510 cases of drug-resistant Shigella were identified in 2023, corroborating the claim.
Fact Check Score
None
Fact Check Weight
0
Web Consensus Score
85
Web Consensus Weight
50
Source Quality Score
85
Source Quality Weight
25
Llm Reasoning Score
80
Llm Reasoning Weight
25
Weighted Total
78
Evidence Summary
CDC and other sources confirm 510 cases identified in 2023.
82
True
Health
No FDA-approved oral antimicrobial agents are available to treat drug-resistant shigella.
The CDC and other health sources confirm that there are no FDA-approved oral antimicrobial agents for treating drug-resistant Shigella, supporting the claim.
Fact Check Score
None
Fact Check Weight
0
Web Consensus Score
90
Web Consensus Weight
50
Source Quality Score
90
Source Quality Weight
25
Llm Reasoning Score
85
Llm Reasoning Weight
25
Weighted Total
82
Evidence Summary
CDC and other sources confirm no FDA-approved oral treatments.
